1.
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
by Dumesic, Daniel A
Endocrine reviews, 2015-10, Vol.36 (5), p.487-525
2.
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
by Rosenfield, Robert L
Endocrine reviews, 2016-10, Vol.37 (5), p.467-520
3.
Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome
by Risal, Sanjiv
Nature medicine, 2019-12, Vol.25 (12), p.1894-1904
4.
Using human genetics to understand the disease impacts of testosterone in men and women
by Ruth, Katherine S
Nature medicine, 2020-02, Vol.26 (2), p.252-258
5.
Characterization of Reproductive, Metabolic, and Endocrine Features of Polycystic Ovary Syndrome in Female Hyperandrogenic Mouse Models
by Caldwell, A. S. L
Endocrinology (Philadelphia), 2014-08, Vol.155 (8), p.3146-3159
6.
Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood
by Tata, Brooke
Nature Medicine, 2018-06, Vol.24 (6), p.834-846
7.
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
by Diamanti-Kandarakis, Evanthia
Endocrine reviews, 2012-12, Vol.33 (6), p.981-1030
8.
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
by Legro, Richard S
The journal of clinical endocrinology and metabolism, 2013-12, Vol.98 (12), p.4565-4592
9.
Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome
by Qi, Xinyu
Nature medicine, 2019-08, Vol.25 (8), p.1225-1233
10.
Divergences in Insulin Resistance Between the Different Phenotypes of the Polycystic Ovary Syndrome
by Moghetti, Paolo
The journal of clinical endocrinology and metabolism, 2013-04, Vol.98 (4), p.E628-E637
11.
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
by Hart, Roger
The journal of clinical endocrinology and metabolism, 2015-03, Vol.100 (3), p.911-919
12.
Polycystic ovary syndrome
by Norman, Robert J, MD
The Lancet (British edition), 2007, Vol.370 (9588), p.685-697
13.
Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS
by Dokras, Anuja
The journal of clinical endocrinology and metabolism, 2016-08, Vol.101 (8), p.2966-2974
14.
Vitamin D Status Relates to Reproductive Outcome in Women With Polycystic Ovary Syndrome: Secondary Analysis of a Multicenter Randomized Controlled Trial
by Pal, Lubna
The journal of clinical endocrinology and metabolism, 2016-08, Vol.101 (8), p.3027-3035
15.
Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
by Domecq, Juan Pablo
The journal of clinical endocrinology and metabolism, 2013-12, Vol.98 (12), p.4655-4663
16.
11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
by O'Reilly, Michael W
The journal of clinical endocrinology and metabolism, 2017-03-01, Vol.102 (3), p.840-848
17.
Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome
by Gibson-Helm, Melanie
The journal of clinical endocrinology and metabolism, 2017-02, Vol.102 (2), p.604-612
18.
Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
by O'Reilly, Michael W
The journal of clinical endocrinology and metabolism, 2014-03, Vol.99 (3), p.1027-1036
19.
Variants in DENND1A Are Associated with Polycystic Ovary Syndrome in Women of European Ancestry
by Welt, Corrine K
The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.E1342-E1347
20.
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
by Randeva, Harpal S
Endocrine reviews, 2012-10, Vol.33 (5), p.812-841
